|
|
|
Multimodal tissue perfusion assessment and monitoring device
The Invention:
Current methods of planning and monitoring are not only expensive and limited but often consume significant amounts of physicians’ limited time. In an ideal world, a device would automatically localize the blood vessels within the tissue to be transferred pre-op with minimal physician time or energy input, and monitoring would be performed across a maximal portion of the flap and continuously using modalities emulating critical aspects of a physical exam (e.g. temperature, color, size/contour), as well as modalities that go beyond qualities that can be detected by a human observer (e.g. high thermal, spatial, and temporal resolution/thermal mapping, terahertz radiation signature). Lower costs of these two steps would be an additional advantage in this hypothetical ideal world.
Benefits:
- Uses multiple imaging modalities to improve accuracy/reliability
- Novel imaging modalities
- Utilizes AI to identify tissue characteristics predictive of vascular compromise/tissue changes earlier than other modalities
- Applies to Microsurgery planning, assessment, monitoring; wound care; vascular surgery and vasculopathy care; diabetes and chronic leg wound and edema care; trauma/extremity salvage
Market Opportunity:
- The medical device manufacturing market is currently $49.8 billion and is expected to grow at a CAGR of 3% to $57.7 billion by 2028. The air purification equipment manufacturing market is currently $7.6 billion and is expected to grow at a CAGR 1.3% to $8.1 billion by 2028.
Intellectual property:
Patent Information:
Title |
App Type |
Country |
Serial No. |
Patent No. |
File Date |
Issued Date |
Expire Date |
Patent Status |
|